159 related articles for article (PubMed ID: 2090716)
1. Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients.
Reihnér E; Angelin B; Rudling M; Ewerth S; Björkhem I; Einarsson K
J Lipid Res; 1990 Dec; 31(12):2219-26. PubMed ID: 2090716
[TBL] [Abstract][Full Text] [Related]
2. Differing effects of cholesterol and taurocholate on steady state hepatic HMG-CoA reductase and cholesterol 7 alpha-hydroxylase activities and mRNA levels in the rat.
Shefer S; Nguyen LB; Salen G; Ness GC; Chowdhary IR; Lerner S; Batta AK; Tint GS
J Lipid Res; 1992 Aug; 33(8):1193-200. PubMed ID: 1431598
[TBL] [Abstract][Full Text] [Related]
3. Studies on the regulation of cholesterol 7 alpha-hydroxylase and HMG-CoA reductase in rat liver: effects of lymphatic drainage and ligation of the lymph duct.
Akerlund JE; Björkhem I
J Lipid Res; 1990 Dec; 31(12):2159-66. PubMed ID: 2090709
[TBL] [Abstract][Full Text] [Related]
4. Regulation of hepatic cholesterol metabolism in man.
Angelin B
Ann Med; 1991 Apr; 23(2):177-80. PubMed ID: 1906288
[TBL] [Abstract][Full Text] [Related]
5. Hepatic cholesterol metabolism in estrogen-treated men.
Angelin B; Olivecrona H; Reihnér E; Rudling M; Ståhlberg D; Eriksson M; Ewerth S; Henriksson P; Einarsson K
Gastroenterology; 1992 Nov; 103(5):1657-63. PubMed ID: 1426886
[TBL] [Abstract][Full Text] [Related]
6. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid treatment in cholesterol gallstone disease: effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, biliary lipid composition, and plasma lipid levels.
Angelin B; Ewerth S; Einarsson K
J Lipid Res; 1983 Apr; 24(4):461-8. PubMed ID: 6854153
[TBL] [Abstract][Full Text] [Related]
8. Hepatic low density lipoprotein receptors, HMG-CoA reductase, and plasma lipids and apolipoproteins in high- and low-responding rhesus monkeys: effect of cholestyramine treatment.
Dory L; Bhattacharyya A; Strong J; Chappuis C
J Lipid Res; 1990 Feb; 31(2):279-87. PubMed ID: 2324647
[TBL] [Abstract][Full Text] [Related]
9. Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment.
Ahlberg J; Angelin B; Einarsson K
J Lipid Res; 1981 Mar; 22(3):410-22. PubMed ID: 7240966
[TBL] [Abstract][Full Text] [Related]
10. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones.
Coyne MJ; Bonorris GG; Goldstein LI; Schoenfield LJ
J Lab Clin Med; 1976 Feb; 87(2):281-91. PubMed ID: 1245792
[TBL] [Abstract][Full Text] [Related]
11. Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short erm feeding of chenodeoxycholic and ursodeoxycholic acid.
Carulli N; Ponz De Leon M; Zironi F; Pinetti A; Smerieri A; Iori R; Loria P
J Lipid Res; 1980 Jan; 21(1):35-43. PubMed ID: 7354253
[TBL] [Abstract][Full Text] [Related]
12. Hepatic cholesterol metabolism in cholesterol gallstone disease.
Reihnér E; Angelin B; Björkhem I; Einarsson K
J Lipid Res; 1991 Mar; 32(3):469-75. PubMed ID: 2066675
[TBL] [Abstract][Full Text] [Related]
13. Effects of short-term treatment with pravastatin on the hepatic synthesis of cholesterol and bile acids in gallstone patients.
Hillebrant CG; Axelson M; Björkhem I; Wang FH; Nyberg B; Einarsson C
Eur J Clin Invest; 1998 Apr; 28(4):324-8. PubMed ID: 9615912
[TBL] [Abstract][Full Text] [Related]
14. The level of 7-dehydrocholesterol in plasma reflects the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase in the human liver.
Axelson M; Angelin B; Hillebrant CG; Reihnér E; Einarsson C
Biochim Biophys Acta; 1998 Nov; 1394(2-3):153-7. PubMed ID: 9795194
[TBL] [Abstract][Full Text] [Related]
15. Bile acid sequestrants: mechanisms of action on bile acid and cholesterol metabolism.
Einarsson K; Ericsson S; Ewerth S; Reihnér E; Rudling M; Ståhlberg D; Angelin B
Eur J Clin Pharmacol; 1991; 40 Suppl 1():S53-8. PubMed ID: 2044645
[TBL] [Abstract][Full Text] [Related]
16. SK&F 97426-A a more potent bile acid sequestrant and hypocholesterolaemic agent than cholestyramine in the hamster.
Benson GM; Alston DR; Bond BC; Gee AN; Glen A; Haynes C; Hickey DM; Iqbal S; Jackson B; Jaxa-Chamiec AA
Atherosclerosis; 1993 Jun; 101(1):51-60. PubMed ID: 8216502
[TBL] [Abstract][Full Text] [Related]
17. Deoxycholic acid treatment in patients with cholesterol gallstones: failure to detect a suppression of cholesterol 7alpha-hydroxylase activity.
Hillebrant C; Nyberg B; Angelin B; Axelson M; Björkhem I; Rudling M; Einarsson C
J Intern Med; 1999 Oct; 246(4):399-407. PubMed ID: 10583711
[TBL] [Abstract][Full Text] [Related]
18. Some effects of chitosan on liver function in the rat.
LeHoux JG; Grondin F
Endocrinology; 1993 Mar; 132(3):1078-84. PubMed ID: 7679967
[TBL] [Abstract][Full Text] [Related]
19. Influence of maternal cholestyramine treatment on cholesterol and bile acid metabolism in adult offspring.
Innis SM
J Nutr; 1983 Dec; 113(12):2464-70. PubMed ID: 6655510
[TBL] [Abstract][Full Text] [Related]
20. Interruption of the enterohepatic circulation of bile acids stimulates the esterification rate of cholesterol in human liver.
Ståhlberg D; Reihnér E; Angelin B; Einarsson K
J Lipid Res; 1991 Sep; 32(9):1409-15. PubMed ID: 1753211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
